The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
7387281 6779930 F 7387281-X 20080924 20110323 20110331 EXP US-GENENTECH-268845 GNEFDAAERSPRD 51 YR F Y 93.878 KG 20110331 CN UNITED STATES

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
7387281 1016141310 C SINGULAIR 1 ORAL 10 MG, QD
7387281 1016141301 PS XOLAIR 1 SUBCUTANEOUS 300 MG, Q4W 700598
7387281 1016141302 C OXYGEN 2 2 L, UNK
7387281 1016141311 C CARDIZEM 1
7387281 1016141317 C PRILOSEC 1 ORAL 20 MG, BID
7387281 1016141320 C CARDIZEM 1 ORAL UNK
7387281 1016141307 C ADVAIR DISKUS 100/50 1
7387281 1016141315 C ALBUTEROL INHALER 2 UNK
7387281 1016141303 C PREDNISONE 2 ORAL 5 MG, QD
7387281 1016141304 C PREDNISONE 2
7387281 1016141305 C THEOPHYLLINE 1 800 MG, QD
7387281 1016141306 C ADVAIR DISKUS 100/50 1 RESPIRATORY (INHALATION) UNK MG, BID
7387281 1016141316 C ASPIRIN 1 ORAL 325 MG, QD
7387281 1016141318 C XANAX 1 ORAL 0.25 MG, PRN
7387281 1016141321 C CITALOPRAM HYDROBROMIDE 1 ORAL 20 MG, QD
7387281 1016141309 C ALLEGRA 1 ORAL 180 MG, QD
7387281 1016141312 C PROTONIX 1 40 MG, BID
7387281 1016141314 C ALBUTEROL 1 UNK
7387281 1016141308 C SPIRIVA 1 RESPIRATORY (INHALATION) 18 A?G/HR, QAM
7387281 1016141313 C REQUIP 1 ORAL 1 MG, QD
7387281 1016141319 C GLIPIZIDE 2 ORAL UNK

Indications of drugs used

Event ID DRUG SEQ INDI PT
7387281 1016141310 ASTHMA
7387281 1016141301 ASTHMA
7387281 1016141302 CHRONIC OBSTRUCTIVE PULMONARY DISEASE
7387281 1016141311 PRODUCT USED FOR UNKNOWN INDICATION
7387281 1016141317 GASTROOESOPHAGEAL REFLUX DISEASE
7387281 1016141320 DEPRESSION
7387281 1016141307 HYPERSENSITIVITY
7387281 1016141315 PRODUCT USED FOR UNKNOWN INDICATION
7387281 1016141303 CHRONIC OBSTRUCTIVE PULMONARY DISEASE
7387281 1016141304 ASTHMA
7387281 1016141305 PRODUCT USED FOR UNKNOWN INDICATION
7387281 1016141306 ASTHMA
7387281 1016141316 ANTICOAGULANT THERAPY
7387281 1016141318 ANXIETY
7387281 1016141321 DEPRESSION
7387281 1016141309 ASTHMA
7387281 1016141312 PRODUCT USED FOR UNKNOWN INDICATION
7387281 1016141314 PRODUCT USED FOR UNKNOWN INDICATION
7387281 1016141308 CHRONIC OBSTRUCTIVE PULMONARY DISEASE
7387281 1016141313 RESTLESS LEGS SYNDROME
7387281 1016141319 BLOOD GLUCOSE INCREASED

Outcome of event

Event ID OUTC COD
7387281 OT
7387281 DS

Reactions reported

Event ID PT
7387281 DYSPNOEA
7387281 URTICARIA
7387281 SWELLING FACE
7387281 SWOLLEN TONGUE

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID DRUG SEQ START DT END DT DUR DUR COD
7387281 1016141310 20000101
7387281 1016141301 20080924
7387281 1016141317 19990101
7387281 1016141320 20080101
7387281 1016141303 19950101
7387281 1016141306 20020101
7387281 1016141316 20050101
7387281 1016141318 20060101
7387281 1016141321 20080101
7387281 1016141309 20000101
7387281 1016141308 20050101
7387281 1016141313 20050101
7387281 1016141319 20080101